NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats - PubMed (original) (raw)
NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats
Chunlong Zhong et al. J Neurotrauma. 2005 Feb.
Abstract
Traumatic brain injury (TBI) produces a rapid and excessive elevation in extracellular glutamate associated with excitotoxicity and secondary brain pathology. The peptide neurotransmitter Nacetylaspartylglutamate (NAAG) suppresses glutamate transmission through selective activation of presynaptic Group II metabotropic glutamate receptor subtype 3 (mGluR3). Thus, inhibition of NAAG peptidase activity and the prolong presence of synaptic NAAG were hypothesized to have significant potential for cellular protection following TBI. In the present study, a novel NAAG peptidase inhibitor, ZJ-43, was used in four different doses (0, 50, 100, or 150 mg/kg). Each dose was repeatedly administered i.p. (n=5/group) by multiple injections at three times (0 time, 8 h, 16 h) after moderate lateral fluid percussion TBI in the rat. An additional group was co-administered ZJ-43 (150 mg/kg) and the Group II mGluR antagonist, LY341495 (1 mg/kg), which was predicted to abolish any protective effects of ZJ-43. Rats were euthanized at 24 h after TBI, and brains were processed with a selective marker for degenerating neurons (Fluoro-Jade B) and a marker for astrocytes (GFAP). Ipsilateral neuronal degeneration and bilateral astrocyte loss in the CA2/3 regions of the hippocampus were quantified using stereological techniques. Compared with vehicle, ZJ-43 significantly reduced the number of the ipsilateral degenerating neurons (p<0.01) with the greatest neuroprotection at the 50 mg/kg dose. Moreover, LY341495 successfully abolished the protective effects of ZJ-43. 50 mg/kg of ZJ-43 also significantly reduced the ipsilateral astrocyte loss (p<0.05). We conclude that the NAAG peptidase inhibitor ZJ-43 is a potential novel strategy to reduce both neuronal and astrocyte damage associated with the glutamate excitotoxicity after TBI.
Similar articles
- NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat.
Zhong C, Zhao X, Van KC, Bzdega T, Smyth A, Zhou J, Kozikowski AP, Jiang J, O'Connor WT, Berman RF, Neale JH, Lyeth BG. Zhong C, et al. J Neurochem. 2006 May;97(4):1015-25. doi: 10.1111/j.1471-4159.2006.03786.x. Epub 2006 Apr 5. J Neurochem. 2006. PMID: 16606367 - NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxia.
Feng JF, Gurkoff GG, Van KC, Song M, Lowe DA, Zhou J, Lyeth BG. Feng JF, et al. Brain Res. 2012 Aug 21;1469:144-52. doi: 10.1016/j.brainres.2012.06.021. Epub 2012 Jun 30. Brain Res. 2012. PMID: 22750589 Free PMC article. - Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI.
Feng JF, Van KC, Gurkoff GG, Kopriva C, Olszewski RT, Song M, Sun S, Xu M, Neale JH, Yuen PW, Lowe DA, Zhou J, Lyeth BG. Feng JF, et al. Brain Res. 2011 Jun 13;1395:62-73. doi: 10.1016/j.brainres.2011.04.022. Epub 2011 Apr 20. Brain Res. 2011. PMID: 21565332 Free PMC article. - Application of Novel Therapeutic Agents for CNS Injury: NAAG Peptidase Inhibitors.
Lyeth BG. Lyeth BG. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 38. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 38. PMID: 26269888 Free Books & Documents. Review. - Blockade of N-acetylaspartylglutamate peptidases: a novel protective strategy for brain injuries and neurological disorders.
Zhong C, Luo Q, Jiang J. Zhong C, et al. Int J Neurosci. 2014 Dec;124(12):867-73. doi: 10.3109/00207454.2014.890935. Epub 2014 Feb 13. Int J Neurosci. 2014. PMID: 24494725 Review.
Cited by
- Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition.
Sedlák F, Kvasnička A, Marešová B, Brumarová R, Dobešová D, Dostálová K, Šrámková K, Pehr M, Šácha P, Friedecký D, Konvalinka J. Sedlák F, et al. ACS Chem Neurosci. 2024 Apr 3;15(7):1342-1355. doi: 10.1021/acschemneuro.3c00494. Epub 2024 Feb 20. ACS Chem Neurosci. 2024. PMID: 38377674 Free PMC article. - mNSCs overexpressing Rimkla transplantation facilitates cognitive recovery in a mouse model of traumatic brain injury.
Ji T, Pang Y, Cheng M, Wang R, Chen X, Zhang C, Liu M, Zhang J, Zhong C. Ji T, et al. iScience. 2023 Sep 14;26(10):107913. doi: 10.1016/j.isci.2023.107913. eCollection 2023 Oct 20. iScience. 2023. PMID: 37810220 Free PMC article. - Deletion of glutamate carboxypeptidase II (GCPII), but not GCPIII, provided long-term benefits in mice with traumatic brain injury.
Ji T, Pang Y, Cheng M, Wang R, Chen X, Zhang C, Liu M, Zhang J, Zhong C. Ji T, et al. CNS Neurosci Ther. 2023 Dec;29(12):3786-3801. doi: 10.1111/cns.14299. Epub 2023 Jun 22. CNS Neurosci Ther. 2023. PMID: 37349952 Free PMC article. - _N_-Acetyl-Aspartyl-Glutamate in Brain Health and Disease.
Morland C, Nordengen K. Morland C, et al. Int J Mol Sci. 2022 Jan 23;23(3):1268. doi: 10.3390/ijms23031268. Int J Mol Sci. 2022. PMID: 35163193 Free PMC article. Review. - Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury.
Arteaga Cabeza O, Zhang Z, Smith Khoury E, Sheldon RA, Sharma A, Zhang F, Slusher BS, Kannan RM, Kannan S, Ferriero DM. Arteaga Cabeza O, et al. Neurobiol Dis. 2021 Jan;148:105201. doi: 10.1016/j.nbd.2020.105201. Epub 2020 Nov 30. Neurobiol Dis. 2021. PMID: 33271328 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous